1 Confavreux C . Defining the natural history of MS: the need for complete data and rigorous definitions . Mult Scler2008; 14: 289 – 291 .
2.
2 Tremlett H Zhao Y Devonshire V . The natural history of secondary-progressive multiple sclerosis . Mult Scler2008; 14: 314 – 324 .
3.
3 Tremlett H Paty D Devonshire V . Disability progression in multiple sclerosis is slower than previously reported . Neurology2006; 66: 172 – 177 .
4.
4 Kaplan E Meier P . Nonparametric estimation from incomplete observations . J Am Stat Assoc1958; 53: 457 – 481 .
5.
5 Leung KM Elashoff RM Afifi AA . Censoring issues in survival analysis . Annu Rev Public Health1997; 18: 83 – 104 .
6.
6 Pittock SJ Mayr WT McClelland RL . Disability profile of MS did not change over 10 years in a population-based prevalence cohort . Neurology2004; 62: 601 – 606 .
7.
7 McLeod JG Barnett MH Macaskill P Williams DB . Long-term prognosis of multiple sclerosis in Australia . J Neurol Sci2007; 256: 35 – 38 .
8.
8 Wolinsky JS Narayana PA O'Connor P . Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial . Ann Neurol2007; 61: 14 – 24 .
9.
9 Tremlett H Devonshire V . Is late onset multiple sclerosis associated with a worse outcome . Neurology2006; 67: 954 – 959 .
10.
10 Tremlett H Paty D Devonshire V . The natural history of primary progressive MS in British Columbia, Canada . Neurology2005; 65: 1919 – 1923 .
11.
11 Tremlett H Devonshire V . Does the season or month of birth influence disease progression in multiple sclerosis . Neuroepidemiology2006; 26: 195 – 198 .